Visit
The molecular chaperone nucleophosmin-1 (NPM1) is involved with cellular epigenetic regulation through nuclear-cytoplasmic protein shuttling, ribosomal assembly, and the maintenance…
Chimeric antigen receptor T-cell (CAR-T) therapies have proven particularly successful in hematological malignancies. However, CAR T-cells still underperform when used…
A study presented during the 2020 American Society of Clinical Oncology and Society for Immunotherapy of Cancer Clinical Immuno-Oncology Symposium,…
Hematopoietic stem cell transplantation (HSCT) is an incredibly powerful tool in the treatment of hematological malignancies. Testament to this is…
The treatment options for cutaneous T-cell lymphoma (CTCL) are currently limited, with research ongoing in several clinical trials. SGX301 (synthetic…
In response to the ongoing COVID-19 pandemic, The American Society of Hematology (ASH) have launched a webpage (https://www.hematology.org/covid-19) containing resources…
Held in Tel Aviv, Israel, the 2020 MDS Foundation meeting gave key updates on novel drug combinations, the impact of…
The spread of novel betacoronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly escalated to a pandemic…
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter